St Vincent's Institute of Medical Research
St Vincent's Institute of Medical Research (SVI) is a nonprofit Australian medical research institute founded in 1951, conducting translational research on cancer, type 1 diabetes, DNA repair, gene editing, and immunology, and serving Australian patients through clinical trials and the islet transplant program.
- Company typePrivate
- Founded1951
- HeadquartersFitzroy, Australia
- Headcount101–250
- GTM typeB2B
- OfferingServices
What St Vincent's Institute of Medical Research does
St Vincent's Institute of Medical Research (SVI) is a nonprofit medical research institute established in 1951 and headquartered at 9 Princes Street in Fitzroy, Victoria, Australia. The institute conducts discovery and translational research into the cause, prevention, and treatment of diseases with major health impact, with active programs spanning cancer, type 1 diabetes, immunology, DNA repair, gene editing, infectious disease, healthy ageing, regenerative medicine, and human genomics and evolution. SVI operates specialized laboratories (Genome Stability, DNA Repair & Recombination, Human Genomics & Evolution, Islet Biology, Immunology) and runs clinical programs including the Tom Mandel Islet Transplant Program (over 100 transplants performed since 2006) and the BANDIT trial of JAK inhibitor baricitinib in type 1 diabetes (results published in the New England Journal of Medicine in 2023). Technology assets include pioneering Prime Editing methods for bone marrow failure syndromes, mRNA-based gene editing delivery with over 10x efficiency versus DNA-based systems, and the BRAIx AI breast cancer risk tool published in The Lancet Digital Health.
The institute's business model is nonprofit and grant-dependent: revenue is generated from NHMRC competitive research grants (recent disclosed tranches totaling over $19M), philanthropic donations including the over-$8M Discovery Fund endowment and Catalyst Circle equipment program, major gifts from foundations such as the Ian Potter Foundation, and event-based fundraising (SVI Golf Day raising $110K). SVI monetizes research infrastructure through its wholly aligned Effica Biolabs contract research organization, which provides bespoke preclinical services for immune-related diseases to pharma and biotech clients, and the ATIC clinical trials network across Australia and New Zealand. As a founding partner of the Aikenhead Centre for Medical Discovery (ACMD) with six academic and hospital partners, SVI shares in a $206M biomedical engineering facility (4,500 sqm, 31 labs, capacity for 900 researchers) that opened on 10 June 2026. SVI does not sell commercial products; its end beneficiaries are Australian patients with cancer, diabetes, heart disease, and rare genetic disorders, served indirectly through research outputs, clinical trials, and the islet transplant program.
St Vincent's Institute of Medical Research firmographics
Firmographics- Name
- St Vincent's Institute of Medical Research
- Legal name
- St Vincent's Institute of Medical Research
- Website
- https://svi.edu.au
- Company type
- Private
- Founded year
- 1951
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- St Vincent's Institute of Medical Research (SVI) is a nonprofit Australian medical research institute founded in 1951, conducting translational research on cancer, type 1 diabetes, DNA repair, gene editing, and immunology, and serving Australian patients through clinical trials and the islet transplant program.
- Ownership category
- akta.pro rank
St Vincent's Institute of Medical Research industry classification
Industry- Product category
- Medical Research
- NAICS
- Scientific Research and Development Services (5417), Testing Laboratories and Services (54138)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
Keywords
Where St Vincent's Institute of Medical Research is headquartered
LocationHeadquarters
- HQ city
- Fitzroy
- HQ country
- Australia
- HQ region
- Oceania
Offices2 records
Markets served
St Vincent's Institute of Medical Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations
Revenue model
- Philanthropic donations: Tax-deductible donations from individuals supporting medical research, including major gifts, recurring donations, and bequests
- Government research grants: Funding from National Health and Medical Research Council (NHMRC), including $5 million NHMRC Synergy Grant and investigator grants
- Discovery Fund endowment: Long-term endowment fund valued at over $8 million providing annual funding for research, recruiting scientists and purchasing equipment
- Catalyst Circle equipment donations: Donations specifically directed to acquiring cutting-edge equipment and technologies for research
Distribution channels1 record
Marketing channels5 records
St Vincent's Institute of Medical Research product offering
Product offeringCore offering
SVI is a nonprofit medical research institute that investigates the cause, prevention, and treatment of diseases including cancer, type 1 diabetes, heart disease, infectious diseases, and age-related conditions. Its deliverable outputs are laboratory research, clinical trials, and translational platforms, anchored by the Aikenhead Centre for Medical Discovery (ACMD) biomedical engineering facility and the Effica Biolabs contract research organization. The institute monetizes its science via government grants (NHMRC), philanthropic donations, and limited contract research services to pharmaceutical and biotechnology clients.
Product overview
St Vincent's Institute of Medical Research (SVI) is a medical research institute focused on discovering new knowledge to improve health outcomes. SVI operates as a collection of specialized research laboratories and services rather than a unified product platform. The Institute's main offerings include the Aikenhead Centre for Medical Discovery (ACMD) - a state-of-the-art biomedical engineering facility, Effica Biolabs - a contract research organization for preclinical testing, and various research platform services including flow cytometry, biobanking, and imaging. SVI's research spans multiple disease areas including cancer, diabetes, immunology, and infectious diseases, supported by clinical trials such as the BANDIT trial for type 1 diabetes.
Differentiator
Problem solved
Functional benefit
Brands
- Effica Biolabs: A contract research organisation offering bespoke preclinical services testing the therapeutic potential of drugs and devices for immune-related diseases, particularly type 1 diabetes.
- ATIC (Australasian Type 1 Diabetes Immunotherapy Collaborative)
Products and services
- Effica Biolabs A contract research organization offering bespoke preclinical services testing the therapeutic potential of drugs and devices for immune-related diseases, particularly type 1 diabetes. Provides animal disease models and human tissue assays to pharmaceutical and biotechnology clients.
- Research Platforms and Services Shared research infrastructure services including flow cytometry, mass spectrometry, micro-CT imaging, biobanking, and ion exchange filters supporting medical research activities.
- Tom Mandel Islet Transplant Program Clinical islet transplant service for patients with type 1 diabetes and severe hypoglycemic unawareness, integrated with SVI's immunology research program.
- ATIC Clinical Trials Network Australasian Type 1 Diabetes Immunotherapy Collaborative (ATIC) - a clinical trials network of adult and paediatric endocrinologists, immunologists, clinical triallists and members of the type 1 diabetes community across Australia and New Zealand, accelerating delivery of immunotherapy for type 1 diabetes.
Quantifiable outcome
- BRAIx AI tool published in The Lancet Digital Health demonstrates superior breast cancer risk prediction
- +3 more outcomes
Companies that use St Vincent's Institute of Medical Research
Customer profileSegments2 records
Ideal customer profiles4 records
St Vincent's Institute of Medical Research technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature5 records
St Vincent's Institute of Medical Research partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and minor.
- St Vincent's Hospital MelbournecoreSVI is a founding partner of the Aikenhead Centre for Medical Discovery (ACMD) along with St Vincent's Hospital Melbourne, located in the St Vincent's Fitzroy Health and Innovation Precinct. This partnership brings together researchers, engineers, clinicians and industry partners under one roof to accelerate translation of research into new technologies, treatments and healthcare solutions.
- Australian Catholic UniversitycorePartner in the $206 million Aikenhead Centre for Medical Discovery (ACMD), contributing to the multidisciplinary environment designed to address pressing healthcare challenges through collaboration between researchers, engineers, clinicians and industry.
- Bionics InstitutecorePartner in the Aikenhead Centre for Medical Discovery (ACMD), working collaboratively with SVI and other founding partners to accelerate medical innovation and translation of research to patient care.
- RMIT UniversitycoreAcademic partner in the Aikenhead Centre for Medical Discovery (ACMD), bringing engineering expertise and research capabilities to the collaborative biomedical engineering centre.
- Swinburne University of TechnologycoreAcademic partner in the Aikenhead Centre for Medical Discovery (ACMD), contributing to the multi-disciplinary research environment designed to accelerate translation of discoveries into healthcare solutions.
- University of MelbournecoreAcademic partner in the Aikenhead Centre for Medical Discovery (ACMD), bringing significant research expertise to the partnership focused on translating medical research into real-world healthcare solutions.
- Children's Medical Research Institute (CMRI)coreSVI researchers Associate Professor Andrew Deans and Dr Sarah Henrikus are key contributors to a national $5 million NHMRC Synergy Grant program led by Professor Hilda Pickett at CMRI, targeting treatment-resistant ALT-dependent cancers.
- University of SydneycoreThe national ALT-dependent cancers research program is administered through the University of Sydney, with SVI and CMRI as delivery partners, working to develop the first targeted treatments for these aggressive cancers.
- University of WollongongcorePartner in the national ALT-dependent cancers research program, collaborating with SVI, CMRI, and University of Sydney to develop targeted treatments for treatment-resistant cancers.
- Australasian Type 1 Diabetes Immunotherapy Collaborative (ATIC)coreSVI leads ATIC, a clinical trials network of adult and paediatric endocrinologists, immunologists, clinical triallists and members of the type 1 diabetes community across Australia and New Zealand, accelerating delivery of immunotherapy for type 1 diabetes.
- Effica Biolabs clientsminorContract research organization offering preclinical testing services to pharma and biotech companies, with close networks with service providers to complement and expand experimental design and testing needs.
- Nanyang Technological University (Singapore)minorFormer institution of Associate Professor Irene Gallego Romero who served as Nanyang Assistant Professor before joining SVI, maintaining potential for ongoing research collaboration.
Scale indicators9 records
Recent moves8 records
Expansion highlights5 records
St Vincent's Institute of Medical Research competitors and assessment
Company assessmentDirect peers
- Walter and Eliza Hall Institute of Medical Research (WEHI): Australia's oldest medical research institute, located in Melbourne, focused on cancer, immune health, and infectious disease. Directly comparable to SVI in scale, scope, and funding model (NHMRC, philanthropy), and shares multiple personnel lineages with SVI.
- Baker Heart and Diabetes Institute: Melbourne-based nonprofit research institute specializing in cardiovascular and metabolic disease. Closely aligned with SVI's diabetes and heart disease programs, sharing clinical translation focus and NHMRC funding model.
- Garvan Institute of Medical Research: Sydney-based medical research institute focused on genomics, cancer, diabetes, and immunology. Comparable in scale, technology platforms (genomics/AI), and research translation approach to SVI.
- Peter MacCallum Cancer Centre: Australia's leading standalone cancer hospital and research centre. Andrew Deans completed his PhD here; SVI's Genome Stability and DNA Repair programs are closely related to Peter Mac's translational cancer research focus.
- Children's Medical Research Institute (CMRI): Active partner with SVI on the $5M NHMRC Synergy Grant for ALT-dependent cancer research. Similar nonprofit model with shared investigators (Andrew Deans, Sarah Henrikus) and a comparable research portfolio in genome stability and cancer.
- Hudson Institute of Medical Research: Melbourne-based medical research institute focused on cancer, infection, and women's and infant health. Comparable scale, structure, and translational research mission to SVI.
- Centenary Institute: Sydney-based nonprofit medical research institute focused on cancer, inflammation, and cardiometabolic disease. Similar funding model and disease-area overlap with SVI's immunology and cancer programs.
- Harry Perkins Institute of Medical Research: Western Australia-based medical research institute covering cancer, heart disease, and genetic diseases. Compares to SVI in scope, NHMRC reliance, and translational research positioning.
- QIMR Berghofer Medical Research Institute: Queensland-based large medical research institute with programs in cancer, infectious disease, and chronic disorders. Similar institute scale, government grant reliance, and translational pipeline to SVI.
- Murdoch Children's Research Institute (MCRI): Large Melbourne-based pediatric medical research institute affiliated with the Royal Children's Hospital. Comparable institute scale, NHMRC/PHRP grant structure, and clinical translation model to SVI.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
St Vincent's Institute of Medical Research social profiles
Digital presenceSt Vincent's Institute of Medical Research compliance and trust
Trust signalCompliance2 records
St Vincent's Institute of Medical Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
St Vincent's Institute of Medical Research leadership team
Management profileNumber of profiles
Profiles11 records
St Vincent's Institute of Medical Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
St Vincent's Institute of Medical Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about St Vincent's Institute of Medical Research
What does St Vincent's Institute of Medical Research do?
SVI is a nonprofit medical research institute that investigates the cause, prevention, and treatment of diseases including cancer, type 1 diabetes, heart disease, infectious diseases, and age-related conditions. Its deliverable outputs are laboratory research, clinical trials, and translational platforms, anchored by the Aikenhead Centre for Medical Discovery (ACMD) biomedical engineering facility and the Effica Biolabs contract research organization. The institute monetizes its science via government grants (NHMRC), philanthropic donations, and limited contract research services to pharmaceutical and biotechnology clients.
Is St Vincent's Institute of Medical Research a public or private company?
St Vincent's Institute of Medical Research is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was St Vincent's Institute of Medical Research founded?
St Vincent's Institute of Medical Research was founded in 1951. It employs 101 to 250 people.
Where is St Vincent's Institute of Medical Research based?
St Vincent's Institute of Medical Research is headquartered in Fitzroy, Australia, in the Oceania region.
How does St Vincent's Institute of Medical Research make money?
Four revenue lines are on record. Philanthropic donations are the primary driver. The others are government research grants, discovery Fund endowment and catalyst Circle equipment donations.
Who are St Vincent's Institute of Medical Research's main competitors?
Direct peers on record are Walter and Eliza Hall Institute of Medical Research (WEHI), Baker Heart and Diabetes Institute, Garvan Institute of Medical Research, Peter MacCallum Cancer Centre, Children's Medical Research Institute (CMRI), Hudson Institute of Medical Research, Centenary Institute, Harry Perkins Institute of Medical Research, QIMR Berghofer Medical Research Institute and Murdoch Children's Research Institute (MCRI).
Does St Vincent's Institute of Medical Research have an API?
No public API is recorded for St Vincent's Institute of Medical Research.
What industry is St Vincent's Institute of Medical Research in?
St Vincent's Institute of Medical Research's product category is Medical Research. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 5417 and its SIC code is 8731.